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Abstract
In this paper we study interactions between stochasticity and time delays in the dynamics
of immune response to viral infections, with particular interest in the onset and development
of autoimmune response. Starting with a deterministic time-delayed model of immune response
to infection, which includes cytokines and T cells with different activation thresholds, we de-
rive an exact delayed chemical master equation for the probability density. We use system size
expansion and linear noise approximation to explore how variance and coherence of stochastic
oscillations depend on parameters, and to show that stochastic oscillations become more regular
when regulatory T cells become more effective at clearing autoreactive T cells. Reformulating
the model as an Itô stochastic delay differential equation, we perform numerical simulations to
illustrate the dynamics of the model and associated probability distributions in different param-
eter regimes. The results suggest that even in cases where the deterministic model has stable
steady states, in individual stochastic realisations, the model can exhibit sustained stochastic
oscillations, whose variance increases as one gets closer to the deterministic stability boundary.
Furthermore, in the regime of bi-stability, whereas deterministically the system would approach
one of the steady states (or periodic solutions) depending on the initial conditions, due to the
presence of stochasticity, it is now possible for the system to reach both of those dynamical states
with certain probability. Biological significance of this result lies in highlighting the fact that
since normally in a laboratory or clinical setting one would observe a single individual realisation
of the course of the disease, even for all parameters characterising the immune system and the
strength of infection being the same, there is a proportion of cases where a spontaneous recovery
can be observed, and similarly, where a disease can develop in a situation that otherwise would
result in a normal disease clearance.
1 Introduction
A functioning immune system is characterised by its ability to effectively recognise and then success-
fully destroy cells infected by foreign pathogens. This can only be achieved, provided the immune
system has the property of self-tolerance, which means that it is able to robustly distinguish healthy
cells from infected cells by discriminating between self- and foreign antigens expressed on the cell
surface [1]. Autoimmunity is a condition that is associated with the breakdown of self-tolerance,
and it is known to cause debilitating, often life-long diseases, such as type-1 diabetes mellitus,
multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus (SLE) [2].
Due to the complexity of interactions between different branches of the immune system, it is
often very difficult to identify one specific cause for the onset of autoimmune disease in a particular
patient, as it is usually a combination of a number of factors, including genetic predisposition, pre-
vious exposure to pathogens, age, gender and many others [3, 4, 5, 6]. In light of a prominent role
often played by pathogenic infections in the onset and progress of autoimmunity, several mecha-
nisms have been identified that explain pathogen-induced autoimmunity. One of them is molecular
mimicry, where immune response against an infection can lead to a breakdown of immune tolerance
due to cross-reaction with one or more self-antigens that share some of their immunological char-
acteristics with a pathogen [7, 8]. This is particularly relevant for autoimmune diseases associated
with viral infections, such as Coxsackie virus for type-1 diabetes [9], and Epstein-Barr virus for
multiple sclerosis [2, 10, 11]. Other possible mechanisms of pathogen-induced autoimmunity are
bystander activation, where T cells specific for an antigen X are activated during immune response
against antigen Y as mediated by cytokines [12], epitope spreading, where self-antigens released
either as a result of direct lysis of self-tissue due to a persisting pathogen, or as part of immune
response to a persisting pathogen, result in a secondary immune response against self-antigens, and
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cryptic antigens that are normally not recognised by the immune system, but as a result of the in-
flammatory environment following an infection, there can be an increase in protease production and
differential processing of released self-epitopes by antigen presenting cells [8]. Very recent murine
and human experiments have shown how a single gut bacterium can trigger autoimmune disease
in different organs by migrating into them [13]. This lends further credence to the importance of
pathogens in mediating autoimmune dynamics.
A number of mathematical models have looked at various aspects of immune dynamics, and in
particular, at onset and development of autoimmune response. They have investigated interactions
between effector and regulatory T cells (Tregs) [14, 15, 16], the role of T cells in coordinating an
effective immune response [17, 18, 19, 20], control of autoimmunity through suppression by Tregs
[21], the role of interleukin-2 (IL-2) in mediating T cell interactions [22, 23, 24, 25], and the effects
of viral population and the growth function of susceptible host cells on the dynamics of immune
response [26, 27]. Grossman et al. [28, 29, 30] proposed an alternative framework of so-called tunable
activation thresholds (TAT) for modelling the behaviour of T cells in the context of autoimmunity.
This approach assumes that the same T cells can perform different immune functions, and they
can also adjust their response to stimulation by autoantigens, and this idea that activation of T
cells can change during their circulation has been confirmed in murine and human experiments
[31, 32, 33, 34]. The importance of tuning lies in the fact that it provides an effective mechanism
for improving sensitivity and specificity of T cell signalling in a noisy environment [35, 36], and
Scherer et al. [37] and van den Berg and Rand [38] developed and analysed stochastic models for
the tuning of activation thresholds.
In the context of autoimmunity arising through a mechanism of molecular mimicry, Blyuss
and Nicholson [39, 40] developed a mathematical model of immune response to a viral infection
with accounting for T cells with tunable activation thresholds. This model has demonstrated how
depending on parameter values, the system can exhibit either normal viral clearance, a sustained
chronic infection, or endogenous periodic oscillations that can be interpreted as periods of relapses
and remissions often observed in clinical manifestations of autoimmune diseases [41, 42, 43]. These
periodic oscillations, however, could only be exhibited by the model, provided the viral population
and the population of infected cells are positive, which does not correspond to clinical observations,
which rather suggest that progression to an autoimmune disease occurs after the initial viral infec-
tion has been fully cleared by the immune system. To overcome this limitation, Fatehi et al. [44] put
forward a more realistic version of the same model, which also includes IL-2 and regulatory T cells.
This modified model was able to capture all of the above-mentioned dynamical regimes, as well
as oscillations in the numbers of autoreactive T cells following clearance of infection. Importantly,
this model also exhibited a regime of bi-stability between a disease-free steady state and periodic
oscillations corresponding to autoimmune response, suggesting a clinically important observation
that it is not only the parameters of the immune system, but also the initial level of infection and
the state of the immune system that determine ultimate outcome of the immune response. To
account for the intrinsically stochastic nature of many aspects of the immune response [45], Fatehi
et al. [46] have explored the effects of stochasticity on the dynamics of immune response in the
model and determined for the same parameter regions probability distribution of different immune
outcomes. This has also provided practically important insights into how variance of stochastic
oscillations depends on different parameters, which is very important for comparison with clinical
observations of individual realisations of progression of autoimmune disease. A complementary
analysis has been performed by Fatehi et al. [47, 48] to investigate the role played by time delays
associated with different aspects of immune response and virus cycle dynamics.
Since both stochasticity and time delays are essential features of the immune system, it is im-
portant to consider how their interactions affect immune dynamics. One of the first computational
approaches to modelling stochastic systems with time delays was proposed by Bratsun et al. [49]
in the context of modelling gene regulation. Subsequently, a number of other delay stochastic sim-
ulation algorithms (DSSAs) were proposed, such as ‘rejection method’ [50], next reaction method
[51], ‘direct algorithm’ [52]. An important point about these more advanced method is that they
are able to effectively simulate two types of delayed reactions, namely, non-consuming delayed re-
actions where the reactants of an unfinished reaction can participate in another reaction, as well
as consuming delayed reactions where the reactants of an unfinished reaction cannot participate
in a new reaction. This distinction proved important in models of gene regulatory networks, but
applies to a wider range of stochastic delayed models. Besides DSSAs, another approach to analy-
sis of stochastic delayed systems is based on the Delay Chemical Master Equations (DCME) that
describe the exact probability distribution of finding the system in a particular state [49, 50]. Leier
and Marquez-Lago [53] have presented the most general formulation of DCMEs, which allows one
to consider both consuming and non-consuming delayed reactions, and for simple reaction schemes
it proved possible to obtain closed form solutions of the DCME. In most cases, however, solving
DCME analytically is impossible, while DSSAs are computationally demanding [54, 55], and in
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such cases one case use stochastic delay differential equations (SDDEs) to obtain good approxi-
mations of probability distributions in stochastic delayed model, which can be obtained in a much
more computationally efficient manner. Tian et al. [54] have developed a method for deriving
SDDEs directly from DCME models, and showed how these SDDEs can be solved using the Euler-
Maruyama method for discrete, as well as distributed time delays. As an alternative, Niu et al.
[56, 57] have introduced a strong predictor-corrector method for the numerical solution of SDDEs.
Fatehi et al. [58] have recently proposed a new method for deriving SDDE models from DCMEs,
which significantly reduces computational complexity.
In this paper, we focus on a fundamental question of how interaction of stochasticity with time
delays affects the dynamics of immune response and autoimmunity. Due to a significant role played
by the cytokines in mediating the proliferation of T cells during immune response, we will pay
particular attention to the time delay associated with this process. As a first step, in the next
Section we will briefly review a time-delayed deterministic model of immune response, summarising
main biological assumptions, as well discussing conditions for stability of various steady states. In
Section 3, we will use this deterministic model as a foundation to derive a delay chemical master
equation (DCME) that exactly describes the probability density function of the model, when all cell
compartment are represented by discrete random variables. In Section 4, we will develop a system-
size expansion of this DCME to obtain a linear-noise approximation (LNA) for fluctuations around
deterministic trajectories. This will allow us to determine the magnitude of stochastic fluctuations,
as well as the coherence of stochastic oscillations around deterministically stable steady states
depends on parameters. Section 5 contains a derivation of an equivalent Itô SDDE model from the
DCME, which will then be used in Section 6 for numerical simulations. The paper concludes in
Section 7 with a discussion of results and open questions.
2 Deterministic model
In order to understand how stochasticity interacts with time-delayed effects in immune dynamics,
we use a model proposed recently by Fatehi et al. [48] to study the dynamics of immune response
to viral infection, which is illustrated in Fig. 1. In this model, A(t) denotes a population of healthy
host cells that is assumed to grow logistically with a linear growth s and a carrying capacity N .
These cells become infected at rate β and move to the compartment F (t) of infected cells. In
agreement with other models of viral dynamics [59, 60, 61], it is assumed that infected cells cannot
themselves proliferate due to infection, which takes over their cellular machinery for the purpose of
producing new virus particles that are subsequently released from such cells upon their lysis. It is,
however, possible to make a straightforward modification of our model that would allow infected
cells to also reproduce logistically in a manner similar to healthy cells [62, 63]. Unlike an earlier
model in [48], we do not explicitly model the population of free virus particles, but instead include
a time delay τ1 to represent the viral lag phase [64], as well as the actual process of infection. In
principle, one could also include in the infection term βA(t−τ1)F (t−τ1) an additional factor e−mτ1
to represent the fraction of already infected cells that survive during the lag period, where m is
the death rate of cells that are already infectious but are not yet producing new virions. This was
proposed by Herz et al. [65], and subsequently used in a number of other models of virus dynamics
[66, 67, 68]. However, to simplify the model we will assume that m is sufficiently small, so that this
factor does not have to be explicitly included, as has been effectively done in a number of virus
models [69, 70, 71].
In terms of immune response, due to the major role played by T cells in autoimmune dynamics,
we focus primarily on their dynamics and do not include B cells, since autoimmune response can
develop even in their absence [72]. It is known that stimulation of näıve T cells by antigens results
in their proliferation and differentiation into activated T cells that then migrate to the infected
tissue [1]. Following activation, T cells that bear CD8+ receptors would become cytotoxic T cells
able to destroy infected cells by triggering their apoptosis. Similarly, T cells with CD4+ receptors
would become helper T cells [1], some of which, CD4+CD25+ T cells, are regulatory T cells that
perform a very important role of suppressing autoreactive T cells [73, 74]. In order to model
autoimmunity arising from a failure of self/non-self discrimination in the immune response, we
consider four distinct populations of T cells, näıve/inactive T cells Tin(t), CD4
+CD25+ regulatory
T cells Treg(t), and two populations of activated CD8
+ T cells, namely, normal activated T cells
Tnor(t), and autoreactive T cells Taut(t). The distinction between normal activated and autoreactive
T cells is that the autoreactive T cells have a lower activation threshold, and, as a result of cross-
reactivity between some of the epitopes in foreign and self-antigens, they destroy not only infected
cells, but also the healthy host cells. Since normal activated T cells are specific to recognising
infected cells only, they will be assumed not to be removed or affected by the regulatory T cells. It
is assumed that both inactive and regulatory T cells are maintained in a homeostasis, i.e. at some
steady levels, in the absence of infection [75]. There are a number of mechanisms involved in this
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Figure 1: A diagram of immune response to an infection. Blue circles indicate host cells (uninfected and
infected cells), red circles denote different T cells (näıve, regulatory, normal activated, and autoreactive T
cells), yellow circle show cytokines (interleukin-2). τi’s inside each of the subnetworks indicate the time
delay in the respective processes. Curves with single arrows or bars indicate, respectively, up-regulation or
down-regulation. Lines with double arrows indicate natural clearance/death.
process, including post-thymic tuning of T cell receptors and anti-apoptotic signals from cytokines,
such as IL-7 and IL-15 in the case of CD8+ cytotoxic T cells [76, 77, 78], and IL-2 in the case of
CD4+ regulatory T cells [79, 80]. Iwami et al. [26, 27] have earlier noted that a functional form
of the term representing homeostasis can also play a role in determining the dynamics of immune
response, and for both näıve and regulatory T cells we choose this function in the form of a constant
production, as well as constant degradation rate. Once the cells become infected and recognised
as such by the immune system, näıve T cells expand and differentiate, and it is assumed that after
some time delay τ3 a proportion p1 of them differentiate into further regulatory T cells, a proportion
p2 become normal activated T cells Tnor(t), and the remaining proportion (1 − p1 − p2) become
autoreactive T cells Taut(t). Choosing p1 = 0 would mean that Tin only contains the pool of inactive
CD8+ cytotoxic T cells (CTLs), from which Tnor and Taut are produced through activation, while
regulatory T cells are maintained by a separate mechanism. The model also includes a cytokine
interleukin-2 (IL-2), which is known to enhance the proliferation of all types of T cells, though it is
only secreted by the cytotoxic T cells, and not by the regulatory T cells [1, 81]. Hence, in the model
we consider that proliferation of T cells Treg, Tnor and Taut is enhanced by IL-2 I(t) at rates ρ1, ρ2
and ρ3, respectively, and this process is characterised by a time delay τ2, while IL-2 is produced by
Tnor and Taut at rates σ1 and σ2. While regulatory T cells may block the expression of IL-2 by T
cells by suppressing IL-2 mRNA, thus restricting T cell proliferation [82, 83, 84], similarly to other
studies that analysed the role of IL-2 in T cell dynamics [85, 86, 87], we do not explicitly include
this mechanism in our model not to increase its complexity. This effect can, however, be included
as an additional term (−γTregI) in the equation for IL-2 [24, 25], though our earlier analysis of an
analogous model has shown that this effect may be smaller compared to other contributions, such
as the suppressive effect of regulatory T cells on autoreactive T cells [47].
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− βAF − µaTautA,
dF
dt
= βA(t− τ1)F (t− τ1)− dFF − µFTnorF − µaTautF,
dTin
dt
= λin − dinTin − αTinF,
dTreg
dt
= λr − drTreg + p1αTin(t− τ3)F (t− τ3) + ρ1I(t− τ2)Treg(t− τ2),
dTnor
dt
= p2αTin(t− τ3)F (t− τ3)− dnTnor + ρ2I(t− τ2)Tnor(t− τ2),
dTaut
dt
= (1− p1 − p2)αTin(t− τ3)F (t− τ3)− daTaut − δTregTaut + ρ3I(t− τ2)Taut(t− τ2),
dI
dt
= σ1Tnor + σ2Taut − diI.
(1)
This model has been analysed earlier in Fatehi et al. [47, 48], who have shown that it has at most
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and it is stable if dF > βN and unstable if dF < βN , irrespective of the values of time delays. The










































2 + (ρ1da − ρ3dr)x∗4 + ρ3λr = 0. (2)












where K = 1 for S∗2 , and K = (βN − dF )/(s+ βN) for S∗3 , and the following equation
∆(τ2, λ) = p2(λ)e
−2λτ2 + p1(λ)e
−λτ2 + p0(λ) = 0, (3)
where
p2(λ) =











2 + [ρ1 (da + δx
∗
4) + diρ1 + 2diρ3 + drρ3]λ




3 + (di + dr + da + δx
∗
4)λ
2 + [di (da + δx
∗
4) + dr (da + δx
∗
4) + didr]λ
+ didr (da + δx
∗
4) ,
only has roots with negative real part. Biologically, the steady state S∗2 represents the death of host
cells, while S∗3 corresponds to an autoimmune state. Depending on parameters, the steady state S
∗
3
can lose its stability through a Hopf bifurcation, which occurs when a pair of characteristics roots of
equation (3) crosses the imaginary axis. In this case, one would observe periodic oscillations around
S∗3 that can be interpreted from immunological perspective as an autoimmune state, characterised
by the clearance of the initial infection, followed by sustained endogenous oscillations in the numbers
of autoreactive T cells [47, 48, 44]. The final steady state S∗4 has all of its components positive,
and it corresponds to the state of chronic infection. Having established conditions for stability
of various steady states, we can now consider how the dynamics of the system is influenced by
stochasticity, and how the stochasticity interacts with different time delays present in the system.
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3 Stochastic model: a delayed chemical master equation
To develop a stochastic version of the model (1), we introduce variables X1(t), . . . , X7(t) ∈ {0, 1, 2,
. . .} as discrete random variables representing, respectively, the numbers of uninfected cells, infected
cells, näıve T cells, regulatory T cells, normal activated T cells, autoreactive T cells, and interleukin
2 (IL-2) at time t, with the initial condition X(t) = ϕ(t) for t ∈ [−τ, 0], where τ = max{τ1, τ2, τ3}.
It is assumed that all these cells interact within some fixed volume Ω. The state change vector
characterising each specific interaction between different cells Rj is denoted by vj , and its propensity
function is given by aj(X(t)) in any given state X(t) = (X1(t), X2(t), . . . , X7(t)). The propensity
functions corresponding to interactions and transitions illustrated in Fig. 1 are given in the system
(12) in Appendix A.
As already mentioned in the Introduction, when deriving the delay chemical master equation
(DCME), one has to carefully account for delayed transitions/interactions. Following an approach
proposed by Barrio et al. [50] and subsequently elaborated by Cai [52] for chemical reactions
(within our model, individual cell populations can be interpreted and chemical reactants, and
interactions between them as reaction), we will divide all reactions into three types: non-delayed
reactions, non-consuming delayed reactions, and consuming delayed reactions. The distinction
between these three types of reaction lies in when the associated state of the system gets updated,
and what the corresponding state change vector is. For non-delayed and non-consuming delayed
reactions, there is a single time point where the update of the system state happens both for
original reactants and for the resulting products - it happens either immediately in the case of non-
delayed reactions, or, respectively, after the end of delay for delayed non-consuming reactions. In
contrast, for consuming delayed reactions, there are two distinct update points: original reactants
are updated at the initiation of reaction, while the products are updated at the end of time delay.
From a biological/chemical point of view, the difference between non-consuming and consuming
delayed reactions is that during non-consuming reactions, reactants can also participate in other
reactions (hence, the name, as reactants are not “consumed” by the reaction), whereas in consuming
reactions, once they start, the reactants are consumed and thus cannot participate in any other
reactions until current reactions finish. As an example, gene transcription can be interpreted as
non-consuming reactions, since it is possible for a single gene to be simultaneously transcribed
by several different RNA polymerases, and moreover, the DNA molecule itself is not consumed
by the first transcription, but is rather available for another transcription even before the end of
the current one. In contrast, transport of compounds within or outside the cell is a consuming
reaction, since the molecules leave one compartment, and after some period of time appear in
another compartment, clearly indicating two different updates: one at the start of reaction, and
another at the end of delay period.
Based on the deterministic model (1), stimulation and subsequent proliferation of activated T
cells with a positive growth signal from IL-2 is a non-consuming delayed reaction. In contrast,
activation of inactive T cells, and production of infected cells from uninfected cells are consuming
delayed reactions. Therefore, the state change vector for these reactions should be split into two
vectors, with one of them indicating the state change in the absence of delays, and the other one
showing the state change of products which occurs with a delay [53].
If we denote the probability of finding the system in the state n = (n1, n2, n3, n4, n5, n6, n7)
with ni ∈ {0, 1, 2, ...} at time t by
P (n, t) = Prob{X(t) = n|ϕ(t)},
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where I(n) is the set of all possible system states in the past, from which the state n is able to
follow via a chain of transitions, P (n, t;m, t − τ) is the joint probability of finding the system in
state n at time t and in state m at time t− τ , and shift operators ε±i are defined as follows,
ε±i f(n1, n2, n3, n4, n5, n6, n7, t) = f(n1, ..., ni ± 1, ..., n7, t), for each 1 ≤ i ≤ 7,
and if ni < 0 for any 1 ≤ i ≤ 7, then P (n, t) = 0.
Since solving this equation analytically is not possible, it can either be simulated numerically
using some DSSAs, which is computationally expensive [54, 55, 88], or one can develop some approx-
imations of this equation that can provide both analytical insights and analogous representations
that are more computationally efficient.
4 System size expansion and fluctuations
To make analytical progress in the analysis of the DCME (4), we will use the so-called system size
expansion, or van Kampen’s expansion [89] that is often used to construct a continuous approxima-
tion for discrete stochastic models [90, 91, 55]. This will allow us to decompose time evolution of
each cell population into deterministic and stochastic components, thus providing a methodology
for analysis of fluctuations around deterministic attractors [55, 92]. In order to apply system size
expansion to the DCME (4), we consider each ni to be of order Ω, with fluctuations of order Ω
1/2,
which can be written as follows,
ni(t) = Ωxi(t) + Ω
1/2ξi(t), i = 1, 2, . . . , 7,
where xi(t) are determined by the deterministic rate equations, and ξi(t) describe random fluctua-
tions around the deterministic solution. Similarly, for delayed variables we write [92]
mi(t− τj) = Ωxi(t− τj) + Ω
1/2ηi(t), i = 1, . . . , 7, j = 1, 2, 3,
where the index j is chosen depending on the delayed reaction being considered. For example, if it
is the reaction of production of infected cells from uninfected cells, then mi(t− τ1) = Ωxi(t− τ1) +
Ω1/2ηi(t), i = 1, 2, . . . , 7.
The probability distributions P (n, t) and P (n, t;m, t − τj) can be written as functions of ξ =
(ξ1, . . . , ξ7)
T and η = (η1, . . . , η7)
T , i.e.
P (n, t) = P (Ωx + Ω
1/2ξ, t) = Π(ξ, t),
















To expand the master equation in a power series in Ω−1/2, we use the following expansions for step
operators ε±i
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and drop tildes for notational convenience. To give two examples, expansions of propensities for




a7(m) = p1αη2η3 +
(
p1αx2(t− τ3)η3 + p1αx3(t− τ3)η2
)
Ω
1/2 + p1αx2(t− τ3)x3(t− τ3)Ω,
with the expansions of remaining propensities given in Appendix B.
Substituting expressions (5) and (6), together with the expansions for propensity functions, into
the DCME (4) shows that the left-hand side of the equation only contains terms of the order Ω1/2
and Ω0, while the right-hand side has terms of the order Ω1/2, Ω0, and Ω−n/2, for n ∈ N, and we
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will ignore the terms of order Ω−n/2 [92, 46]. To show how the process of substitution works, let
us illustrate expansions for one non-delayed term
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with all other terms being computed in the same way. After substitution, collecting terms of order
Ω1/2 yields system (1) describing macroscopic behaviour of the model.
At the next order, i.e. at order Ω0, we obtain a linear delayed Fokker-Planck equation, known as
the linear noise approximation (LNA), that describes stochastic fluctuations around a deterministic
trajectory, as shown in Appendix C. Following Phillips et al. [55], we use the structure of
this equation to derive a system of equations that describes the delayed Langevin dynamics of
fluctuations around any deterministic steady states S∗ = (x∗1, x
∗
2, . . . , x
∗
7) of the model (1). This
system has the form
ξ̇1 = (s− 2d2x∗1 − βx∗2 − µax∗6)ξ1 − βx∗1ξ2 − µax∗1ξ6 + ζ1,
ξ̇2 = βx
∗
2ξ1(t− τ1) + βx∗1ξ2(t− τ1)− (dF + µFx∗5 + µax∗6)ξ2 − µFx∗2ξ5 − µax∗2ξ6 + ζ2,
ξ̇3 = −αx∗3ξ2 − (din + αx∗2)ξ3 + ζ3,
ξ̇4 = −drξ4 + p1αx∗3ξ2(t− τ3) + p1αx∗2ξ3(t− τ3) + ρ1x∗7ξ4(t− τ2) + ρ1x∗4ξ7(t− τ2) + ζ4,
ξ̇5 = −dnξ5 + p2αx∗3ξ2(t− τ3) + p2αx∗2ξ3(t− τ3) + ρ2x∗7ξ5(t− τ2) + ρ2x∗5ξ7(t− τ2) + ζ5,
ξ̇6 = −δx∗6ξ4 − (da + δx∗4)ξ6 + (1− p1 − p2)αx∗3ξ2(t− τ3) + (1− p1 − p2)αx∗2ξ3(t− τ3)
+ρ3x
∗
7ξ6(t− τ2) + ρ3x∗6ξ7(t− τ2) + ζ6,
ξ̇7 = σ1ξ5 + σ2ξ6 − diξ7 + ζ7,
(7)
where ζ(t) = (ζ1(t), ζ2(t), . . . , ζ7(t))
T is a vector of seven independent Gaussian white noise variables
with zero mean, and the noise correlators given by








〈ζ2(t)ζ2(t′)〉 = (βx∗1x∗2 + dFx∗2 + µFx∗2x∗5 + µax∗2x∗6)δ(t− t′),
〈ζ3(t)ζ3(t′)〉 = (λin + dinx∗3 + αx∗2x∗3)δ(t− t′),
〈ζ4(t)ζ4(t′)〉 = (λr + drx∗4 + p1αx∗2x∗3 + ρ1x∗4x∗7)δ(t− t′),
〈ζ5(t)ζ5(t′)〉 = (p2αx∗2x∗3 + dnx∗5 + ρ2x∗5x∗7)δ(t− t′),
〈ζ6(t)ζ6(t′)〉 =
(
(1− p1 − p2)αx∗2x∗3 + dax∗6 + δx∗4x∗6 + ρ3x∗6x∗7
)
δ(t− t′),
〈ζ7(t)ζ7(t′)〉 = (σ1x∗5 + σ2x∗6 + dix∗7)δ(t− t′),
〈ζi(t)ζj(t′)〉 = 0, ∀ i 6= j.
Using a Fourier transformation of the model (7), one can find the power spectral density (PSD)
of the fluctuations, which can be used to determine the variance and coherence of stochastic oscil-
lations. Fourier transform of the model (7) gives
M(ω)ξ̃(ω) = ζ̃(ω),
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where M(ω) = iωI −M1 − e−iωτ1M2 − e−iωτ2M3 − e−iωτ3M4, and
M1 =

s− 2d2x∗1 − µax∗6 − βx∗2 −βx∗1 0 0 0 −µax∗1 0
0 −dF − µFx∗5 − µax∗6 0 0 −µFx∗2 µax∗2 0
0 −αx∗3 −din − αx∗2 0 0 0 0
0 0 0 −dr 0 0 0
0 0 0 0 −dn 0 0
0 0 0 −δx∗6 0 −da − δx∗4 0





βx∗2, if (i, j) = (1, 2),






7, if (i, j) = (4, 4),
ρ1x
∗
4, if (i, j) = (4, 7),
ρ2x
∗
7, if (i, j) = (5, 5),
ρ2x
∗
5, if (i, j) = (5, 7),
ρ3x
∗
7, if (i, j) = (6, 6),
ρ3x
∗






3, if (i, j) = (4, 2),
p1αx
∗
2, if (i, j) = (4, 3),
p2αx
∗
3, if (i, j) = (5, 2),
p2αx
∗
2, if (i, j) = (5, 3),
(1− p1 − p2)αx∗3, if (i, j) = (6, 2),
(1− p1 − p2)αx∗2, if (i, j) = (6, 3),
0, otherwise.


































































7, if i = 5,







7, if i = 7.
Using this approach, it can be easily shown that in the case where the macroscopic model (1)
converges to either of the steady states S∗2 or S
∗
3 , the power spectrum for the number of regulatory
T cells (S4,4(ω)), which is denoted as Pr(ω), is given by
Preg(ω) =
b4|L|2 + b6σ22ρ21x∗42 + b7ρ21x∗42
∣∣iω + da + δx∗4 − ρ3e−iωτ2x∗7∣∣2
| det(D)|2
, (8)
where L = (iω + di)
(







iω + dr − ρ1e−iωτ2x∗7 0 −ρ1e−iωτ2x∗4
δx∗6 iω + da + δx
∗ − ρ3e−iωτ2x∗7 −ρ3e−iωτ2x∗7
0 −σ2 iω + di
 ,
and the PSDs of other state variables can be obtained in a similar way.
At any steady state, the covariance matrix Ξ with Ξij = 〈ξi(t)ξj(t)〉−〈ξi(t)〉〈ξj(t)〉 = 〈ξi(t)ξj(t)〉












To relate the results of this analysis to the outcome of direct numerical simulations of the stochastic
model, it is instructive to express the covariance matrix in terms of actual numbers of cells in each
compartment, rather than deviations from stationary values. This can be achieved by defining the
covariance matrix C as Cij = 〈(ni − 〈ni〉)(nj − 〈nj〉)〉, which is related to Ξ through Cij = ΩΞij
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Figure 2: Coherence of stochastic oscillations c defined as the spectral power associated with a range of
frequencies around the peak Ap relative to the total area under the PSD curve A0 [55, 95].
[46]. When there is no delay, as an alternative to numerical computation of matrices Ξ and C by
evaluation of the matrix of spectra S(ω) and its subsequent numerical integration, one could also
determine these matrices by solving the corresponding Lyapunov equation [46, 94]. Either of those
approaches allows one to compute the value of variance of fluctuations around any steady state of
the deterministic model.
In order to quantify how well-structured stochastic oscillations are around the dominant spectral
frequency for any of the relevant state variables, we can use the notion of coherence [55, 93,
95]. Choosing a particular state variable X(t), we can consider the power spectral density P (ω)
of stochastic oscillations of this variable around its steady state value X∗. The overall level of









Focusing on the particular interval of frequencies [ω1, ω2] around the peak frequency in the distri-





and then define coherence of stochastic oscillations as c = Ap/A0 [55, 95].
5 Itô SDDE model
Using the method presented in [58], we now derive a computationally efficient SDDE model associ-
ated with the DCME (4). Let Y(t) = (Y1(t), Y2(t), Y3(t), Y4(t), Y5(t), Y6(t), Y7(t))
T be a continuous
random vector for the sizes of various cell compartments at time t, and ∆t be small enough so that
during this time interval at most one change can occur in state variables. These changes together
with their probabilities are listed in Table 2 in Appendix D. In this table, reactions 3, 7, 8 and 9
that are associated with infection and proliferation of different types of T cells from näıve/inactive
T cells are consuming delayed reactions; reactions 11, 13 and 15 describing the delayed impact of
IL-2 on proliferation of different types of T cells are non-consuming delayed reactions; all other
reactions are non-delayed. According to the methodology of Fatehi et al. [58], the order of these
reactions in the table is irrelevant, since they all come in with associated state change vectors.
The assumption of only a single transition/reaction occurring during a small time interval is a
fundamental premise of all stochastic models using the framework of master equation, irrespective
of whether they are non-delayed, or delayed, and the same applies to associated stochastic simu-
lations algorithms [52, 54, 96, 88]. Using Table 2 of possible state changes, one can compute the
expectation vector and covariance matrix of ∆Y for sufficiently small ∆t.












P7 + P10 + P11 − P12
P8 + P13 − P14
P9 + P15 − P16
P17 − P18

is the drift vector, which is identical to the right-hand side of the deterministic model (1). The









P1 + P2 0 0 0 0 0 0
0 P3 + P4 0 0 0 0 0
0 0 P5 + P6 0 0 0 0
0 0 0 P7 + P10 + P11 + P12 0 0 0
0 0 0 0 P8 + P13 + P14 0 0
0 0 0 0 0 P9 + P15 + P16 0
0 0 0 0 0 0 P17 + P18

is a 7× 7 diffusion matrix. Since Σ is a diagonal matrix, it is straightforward to find the matrix Q,
which is also a diagonal matrix with entries Qii =
√
Σii for 1 ≤ i ≤ 7, which satisfies the condition
QQT = Σ. The Itô SDDE model is then given by{
dY(t) = µdt+QdW(t),
Y(t) = ϕ(t) for t ∈ [−τ, 0],
(10)
where τ = max{τ1, τ2, τ3}, and W(t) = [W1(t),W2(t), . . . ,W7(t)]T is a vector of seven independent
Wiener processes, and ϕ(t) is the vector of initial conditions. In the next section we will use this
SDDE for numerical simulations to illustrate various dynamical behaviours of the model.
Having now encountered a number of different formulations of the same model, in the Table
1 below, we provide a summary of different modelling approaches along with their strengths and
weaknesses.
Table 1: Comparison of different modelling formulations
Method Strengths Weaknesses
DDEs
Possibility of analytical results Only covers deterministic dynamics
Ease of numerical simulations and
bifurcation analyses
DSSAs
Stochastically exact Computationally expensive
No analytical results
DCMEs
Describes exact probability distribution Difficult/impossible to solve analytically
Serves as a basis for SDDEs
SDDEs Computationally efficient An approximation; only works for sufficiently
large system size and sufficiently large delays
LNA
Approximates the PDF An approximation; only works for sufficiently
Allows to determine the variance and large system sizes, and in close proximity of
coherence of oscillations deterministic solutions
6 Numerical stability analysis and simulations
In order to perform numerical simulations of the model (10), we use the strong predictor-corrector
method with the degree of implicitness in the drift coefficient chosen to be equal to 1/7, since
for this value the method has the largest stability region [97, 98]. It has been previously shown
[47, 48] that in the model (1), the disease-free steady state S∗1 undergoes a transcritical bifurcation
at βN = dF , where β is the infection rate, N is the carrying capacity of uninfected cells, and dF is
the natural death rate of infected cells. For βN < dF , the disease-free steady state is stable, while
the chronic infection steady state S∗4 is infeasible. On the contrary, for βN > dF , the disease-free
steady state is unstable, and in this case we can study the stability of the chronic infection steady
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Figure 3: Numerical simulation of the model (10) with parameter values from Table 3, with µa = 2, where
µa is the removal rate of uninfected cells by autoreactive T cells, x2(0) = 2 with a constant history, and
the initial condition (11). Blue and green curves represent two sample trajectories of the SDDE (10) that
have entered the basins of attraction of steady states S∗3 and S
∗
1 , respectively. Shaded areas around them
them indicate regions of one standard deviation from the mean of 20000 simulations. Black curve is the
deterministic trajectory of the DDE model (1).
state [47, 48]. This qualitative distinction between different regimes suggests that it is feasible to
consider the two cases separately. First, we consider a situation corresponding to the parameter
regime βN < dF , with the values of parameters given in Table 3 in Appendix E [46, 96]. The
initial condition is chosen to be
(x1(s), x3(s), x4(s), x5(s), x6(s), x7(s)) = (18, 7.2, 6.3, 0, 0, 0),
s ∈ [−τmax, 0], τmax = max{τ1, τ2, τ3},
(11)
to model a situation at the start of infection, where there is some positive number of infected
cells F , but there are still no regulatory, normal or activated T cells that have emerged through
activation of näıve/inactive T cells.
Figure 3 shows the result of 20000 simulations with the initial condition (11) and x2(0) = 2 and
µa = 2, where µa is the removal rate of uninfected cells by autoreactive T cells. In this case, in the
deterministic model (1) the steady states S∗1 and S
∗
3 are both stable, but based on the chosen initial
condition, the system is deterministically in the attraction basin of S∗3 . This figure also shows single
stochastic trajectories around S∗1 and S
∗
3 , as well as areas of one standard deviation from the mean
in the basins of attraction of these steady states (computed from averaging 20000 simulations), in
which trajectories show sustained stochastic oscillations [99, 100]. Taking an average of a large
number of simulations that enter the basin of attraction of S∗3 would show a decaying oscillations
around S∗3 , which is similar to a deterministic trajectory, while single stochastic trajectories exhibit
sustained stochastic oscillations [95, 101]. The reason for this is that at the highest order in the
system size, the dynamics of the DCME is captured by the system (1), which is nothing else but the
original model (1), and similarly, the main contribution to the SDDE is given by the drift vector
that also coincides with the deterministic DDE model, while the diffusion term covers fluctuations
around those deterministic trajectories [96, 102]. One should also note that with the system being
deterministically the system in the attraction basin of the autoimmune steady state S∗3 , it was still
possible for a small number of realisations (around 1.5% of the total number) to successfully clear
the infection and reach a disease-free steady state, which corresponds to a spontaneous recovery.
Figure 4(a) illustrates temporal evolution of the probability distribution for the same set of
parameters and initial condition as in Fig. 3. The bi-stability between steady states S∗1 and S
∗
3
results in the system reaching a bimodal stationary distribution after some initial transient, as
shown in Fig. 4(b). Increasing the value of the rate µa, at which autoreactive T cells are destroying
infected and healthy host cells, from 2 to 3.33 shifts dynamical behaviour for the deterministic
model (1) to a regime of bi-stability between steady states S∗1 and S
∗
2 . In this case, with the same
initial condition (11) and x2(0) = 2.2, the system is in the basin of attraction of S
∗
2 . Figures 4(c)
and (d) show the evolution of the probability distribution, as well as the final bimodal distribution
in this case. Since the size of fluctuations around deterministic solutions scales as Ω−1/2, increasing
the size of system Ω would result in the stochastic trajectories being more narrowly centred around
deterministic solutions, and, as a result, these bimodal distributions becoming closer to unimodal
[92, 102, 103].
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Figure 4: Probability distribution of solutions out of 20000 simulations of the model (10). (a) and (b) with
parameters from Table 3 except for µa = 2, where µa is the removal rate of uninfected cells by autoreactive T
cells, and the initial condition (11) with x2(0) = 2 with a constant history. (c) and (d) with parameters from
Table 3 except for µa = 3.33, and the initial condition (11) with x2(0) = 2.2. In (a) and (c), the probability
histogram is fit to a bimodal normal distribution at different times. (b) and (d) illustrate stationary joint
probability histograms.
A recent work by Fatehi et al. [46] explored how the basins of attraction of steady states S∗1 , S
∗
2
and S∗3 (or periodic orbits around around them) are affected by stochasticity. It showed how in the
regime of bi-stability, where deterministically depending on the initial conditions for the numbers
of infected cells and regulatory T cells, the system is in the basin of attraction of one of those
steady states or associated periodic orbits, under the influence of stochasticity the deterministic
boundary separating basins of attraction of these different states is smeared out, and for any initial
conditions there is some positive probability or reaching either of the states. In contrast, time
delays were shown not to have a major effect on changing the boundaries of basins of attraction,
besides switching stable steady states into periodic orbits around those steady states [44, 47].
Figure 5 highlights the main difference between deterministic and stochastic models by illus-
trating how the coherence of stochastic oscillations changes in the region where S∗2 and S
∗
3 are
deterministically stable, i.e. the deterministic solution exhibits damped oscillations that eventually
reach a steady state. This figure indicates that by increasing time delay τ2 associated with the
effects of IL-2 on proliferation of T cells, we approach the boundary of the Hopf bifurcation, and
the coherence also increases, while in the region where deterministically the model has a periodic
solution around these steady states, the value of coherence is equal to one. Biologically, this means
that in the parameter region where deterministically the system exhibits damped oscillations, due
to stochasticity there would be stochastic oscillations, and they would be becoming more coherent,
i.e. having a frequency spectrum more narrowly distributed around the leading frequency, when
parameters approach the deterministic stability boundary.
Using equation (9), we can determine the covariance matrix C, which provides the variance of
individual state variables, when the deterministic model is at one of its steady states. Figure 6
illustrates how variance in the number of regulatory T cells Treg, as determined by C4,4, varies with
system parameters in the parameter regions where S∗3 is deterministically stable. One can observe
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Figure 5: Coherence of oscillations in the stability regions of S∗2 (a) and S
∗
3 (b) with parameter values from
Table 3, except for ρ3 = 0.667, where ρ3 is the proliferation rate of autoreactive T cells by IL-2. Black curves
show deterministic boundaries of Hopf bifurcation for respective steady states. In the white region, the
steady state S∗2 is infeasible, in the blue region the steady state S
∗
3 is infeasible, and in the region indicated
by the black grid both steady states S∗2 and S
∗
3 are infeasible.
that as one gets closer to the border between the area, where S∗3 is stable, and the area, where the
deterministic model can have a periodic solution around S∗3 , the variance of stochastic oscillations
in Tregs increases. Moreover, this variance increases with the rate σ2 of production of IL-2 by
autoreactive T cells, as well as with the time delay τ2 associated with stimulation and proliferation
of T cells by IL-2. In contrast, Figure 6(b) suggests that the variance of stochastic oscillations in
Tregs is insensitive to changes in the rate µa of destruction of infected and healthy host cells by
autoreactive T cells. The value of variance shown in this figure coincides with the value of variance
computed from the average of 20000 simulations shown in Fig. 3.
To illustrate biological significance of simultaneous presence of time delays and stochasticity, in
Fig. 7 we fix the values of all parameters as in Table 3 and explore the role of initial conditions for
different values of time delays. In the case where all time delays are equal to zero, deterministically
the system approaches a disease-free steady state S∗1 for sufficiently small initial number of infected
cells F (0) and/or for sufficiently large initial number of regulatory T cells Treg(0). Due to stochas-
ticity, the deterministic boundary separating basins of attraction of these two steady states becomes
smeared, and there is a non-zero probability that the system will approach either of these steady
states on both sides of the deterministic boundary separating their basins of attraction. When
time delays are chosen to have the values as given in Table 3, the shape of the region delineating
deterministic basins of attraction of these two steady states changes, and it is deterministically
possible for the system to approach a disease-free steady state S∗3 even for large initial values of
the number of infected cells, provided the initial number of Tregs is sufficiently small. As the time
delay τ2 is increased, this makes the steady state S
∗
3 lose stability, and Figure 7(c) illustrates a
regime of bi-stability between a disease-free steady state S∗1 and a periodic solution around S
∗
3 ,
which represents an autoimmune state. In this case, there is a range of initial numbers of infected
cells, for which, provided the initial number of Tregs is sufficiently low, the majority of solutions
would go to autoimmune state, while a small proportion of them would be able to clear the infection
without any lasting consequences. For higher initial numbers of infected cells, this escape to disease
clearance (which deterministically is impossible) can only take place provided the initial numbers
of Tregs lie in a certain range. Conversely, in the case where deterministically the system would
approach a disease-free steady state, there is now a non-zero probability that some proportion of
stochastic realisations will go on to develop autoimmunity for the same values of parameters and
the same initial conditions.
Now we consider a situation where βN > dF , in which case deterministically the disease-free
steady state S∗1 is unstable, and we can investigate stability of the chronic steady state S
∗
4 . Earlier
results by Fatehi et al. [47, 48] indicate that for parameter values from Table 3, but with δ = 5.3e-4,
σ2 = 0.66 and β = 0.14, where δ is the clearance rate of autoreactive T cells by regulatory T cells,
σ2 is the production rate of IL-2 by autoreactive T cells, and β is the infection rate, the steady states
S∗3 and S
∗
4 are both deterministically stable, and for the initial condition (11) with x2(0) = 0.6 and
x4(0) = 36 with a constant history, the model (1) is in the basin of attraction of the chronic steady
state S∗4 .
Figure 8 shows the results of 20000 stochastic simulations with these parameter values and
initial conditions. Since deterministically S∗4 is stable, and the system is in its basin of attraction
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Figure 6: Variance of the number of regulatory T cells with parameter values from Table 3, but µa = 2
(removal rate of uninfected cells by autoreactive T cells) using equation (9). Coloured regions indicate areas
in respective parameter planes where the autoimmune steady state S∗3 is deterministically stable. Black lined
area indicates the region where S∗3 is infeasible, and in the white region it is feasible but unstable.
for the specific chosen initial conditions, the majority of stochastic trajectories also enter the basin
of attraction of S∗4 . Due to bi-stability, a proportion of these trajectories (about 17.5%) go to S
∗
3 .
Interestingly, although the disease-free steady state is deterministically unstable, fewer than two
percent of trajectories still approach S∗1 and exhibit stochastic oscillations around it. The impact of
these trajectories can be observed in Fig. 8(b), which shows temporal evolution of the probability
distribution of the solutions. In this figure, initially one observes a trimodal probability distribution,
where the middle peak corresponds to trajectories approaching S∗1 . Over time, this peak disappears,
while the peak at S∗3 becomes more pronounced. Since the proportion of trajectories going to S
∗
1
is very small, and the amounts of healthy cells A in the steady states S∗4 and S
∗
1 are close, the
stationary probability distribution is effectively bimodal with peaks at S∗3 and S
∗
4 . However, the
presence of a small number of trajectories approaching the steady state S∗1 results in a small
reduction of the peak associated with the chronic steady state S∗4 .
Figure 9 illustrates how the coherence of stochastic oscillations around the chronic steady state
S∗4 changes with parameters. We observe that the general trend is similar to that shown earlier
in Fig. 5 for steady states S∗2/S
∗
3 in that approaching the deterministic boundary of the Hopf
bifurcation results in the increase of coherence, while increasing the rate δ at which regulatory T
cells suppress autoreactive T cells reduces the coherence of stochastic oscillations. When this rate
is very small, the chronic steady state S∗4 is infeasible, and once δ increases past some minimum
threshold, the steady state S∗4 becomes feasible but unstable, with a deterministic periodic orbit
around it, which corresponds to the maximum level of coherence. Increasing δ further results
in stabilisation of the steady state S∗4 and a reduced coherence of stochastic oscillations around
the stable steady state. There is a major difference in behaviour with regards to effects of time
delays. For the time delay τ2, associated with stimulation and proliferation of T cells by IL-2,
there are multiple stability switches in the stability of S∗4 for intermediate values of δ, which leads
to successive growth and reduction in the level of coherence. In contrast, increasing time delay
τ3, which characterises a lag in proliferation and differentiation of näıve T cells, there is a single
stability switch, with coherence being low for small values of this time delay, then increasing all the
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Figure 7: Probability of solution entering and staying in the basin of attraction of the disease-free steady
state S∗1 . Black curves indicate boundaries between different basins of attraction in the deterministic model,
with parameter values from Table 3, except for τi = 0 (a), all delays as in Table 3 (b) and (c), except for




3 , (c) shows the regime of
bi-stability between a stable steady state S∗1 and a periodic solution around the autoimmune steady state
S∗3 .
Figure 8: (a) Numerical simulations and (b) probability distribution out of 20000 simulations of the model
(10) with parameter values from Table 3, except for δ = 5.3e-4, σ2 = 0.66 and β = 0.14, where δ is the
clearance rate of autoreactive T cells by regulatory T cells, σ2 is the production rate of IL-2 by autoreactive
T cells, and β is the infection rate, and the initial condition (11) with x2(0) = 0.6 and x4(0) = 36 with
a constant history. In (a) blue, red and green are sample trajectories, which have entered the basins of




3 , respectively. Black curve is the deterministic trajectory of the model (1),
and the shaded areas indicate the regions of one standard deviation from the mean. In (b) the probability
histogram is fit to a multimodal normal distribution at different times.
way up to the boundary of Hopf bifurcation, and being at its maximum value subsequently. From a
biological perspective, these results indicate that in the parameter region, where the chronic steady
state is feasible and stable, as regulatory T cells become more effective in suppressing autoreactive
T cells (higher δ), this results in stochastic oscillations around the chronic steady state becoming
less regular, and for sufficiently high values of δ, low-coherence stochastic oscillations are observed
for arbitrarily large values of time delays τ2 and τ3.
In Fig. 10 we illustrate how the variance in the number of regulatory T cells Treg for the steady
states S∗3 or S
∗
4 changes with parameters in the region where these states are deterministically
stable. One observes some notable differences in the behaviour of variance for these two steady
states. For example, while for the steady state S∗3 the variance appears to be almost completely
independent on the rate µa, at which autoreative T cells are destroying healthy host cells, for the
steady state S∗4 the variance substantially decreases with the increase of this rate. Also, due to the
difference in that there is a single loss of stability of S∗3 depending on the time delay τ2 compared
to several stability switches for S∗4 , one observes a monotonic increase of variance for increasing
values of τ2 for S
∗
3 , whereas in the case of S
∗
4 , periods of increased variance are followed by periods
of decreased variance until it settles on some steady level.
7 Discussion
In this paper we have analysed stochastic aspects of immune response against a viral infection with
account for T cells with different activation thresholds, regulatory T cells, as well as the cytokine
mediating T cell activity, while paying particular attention to viral and cytokine delays. Using the
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Figure 9: Coherence of oscillations in the region of stability of S∗4 with parameters from Table 3, except for
σ2 = 0.66 (production rate of IL-2 by autoreactive T cells) and β = 0.14 (infection rate). Black curves show
the deterministic boundary of Hopf bifurcation. The steady state S∗4 is infeasible in the region indicated
with a black grid.
framework of delayed chemical reactions, we have carefully reinterpreted various transitions and
interactions in the model as discrete stochastic changes in the populations of state variables to derive
a delayed chemical master equation that describes the dynamics of the probability distribution of
finding the system in a particular state. To make further progress, we used the formalism of
consuming and non-consuming delayed reactions to reformulate the DCME as an SDDE. We have
proven the equivalence between different formulations of the resulting SDDE, which are identical
in terms of probability distribution and sample paths. Using this equivalence, we have proposed an
alternative formulation of the SDDE, which is much more amenable to direct numerical treatment.
Applying system size expansion to the exact DCME, we have derived a linear Langevin model for
our system that characterises stochastic fluctuations around deterministic trajectories, and used this
information to derive expressions for the variance of stochastic fluctuations around deterministically
stable steady states.
Numerical simulations of the model indicate an intricate interplay between bi-stability and
stochasticity. While deterministically the system can be in a basin of attraction of one particular
steady state for a chosen combination of parameters, due to stochasticity it rather has a bi-modal
probability density distribution, with a proportion of trajectories approaching another stable steady
state. We have illustrated this feature by exploring stochastic basins of attraction of different steady
states and periodic orbits depending on time delays. Moreover, we have observed that in a small
number of realisations, solutions trajectories may exhibit oscillations around the disease-free steady
state, which itself is unstable, and the system possesses a stable chronic steady state, suggesting
theoretical possibility of a spontaneous clearance of infection. The reason for this is that, as is
clear from the Table 2, the disease-free state is an absorbing state of the stochastic model, and
thus, provided this model is run for long enough, the solutions would reach the disease-free state
state and they stay there. However, since we are only performing simulations over a limited time
interval, we rather observe a quasi-stationary distribution [104]. The effect of time delays consists
in possibly destabilising some of the steady states, and in each case the computations indicate
that the variance of stochastic oscillations around deterministically stable steady states increases
as one approaches the stability boundary from the stable side. We have also observed that some
parameters may have almost no effect on the variance of oscillations around one steady state, while
having a significant effect on the variance of oscillations around another steady state for all other
values of parameters being the same. Increasing the rates of homeostatic production of regulatory
T cells λr or the rate of suppression of autoreactive T cells by regulatory T cells δ results in the
reduction of variance of oscillations.
An important practical observation concerns the difference between mean, or averaged, dynam-
ics and the behaviour of individual stochastic realisations [46]. Even in the case when determinis-
tically, or as a result of averaging of a large number of simulations, the system can be settling on a
stable steady state, individual realisations can still exhibit sustained stochastic oscillations around
that steady state. Since the normal laboratory or clinical practice deals with single observations of
individual patients, this result suggests the importance of properly accounting for stochastic effects
when developing realistic models of immune dynamics. Numerical simulations of the SDDE model
have illustrated the behaviour of individual stochastic trajectories, as well as the time evolution of
the probability distribution of the solutions.
There are a number of interesting potential extensions of this work. In terms of more accu-
rate representation of immune response, one could consider including in the model the effects of
regulatory T cells on controlling IL-2 secretion [47, 22], as well as memory T cells [105, 106]. A
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Figure 10: Variance of the number of regulatory T cells with parameter values from Table 3 and β = 0.14
(infection rate), but in (e) and (f) ρ1 = 5.55 (proliferation rate of regulatory T cells by IL-2) using equation
(9). In the left (respectively, right) column, coloured regions indicate areas of respective parameter planes
where the autoimmune (respectively, chronic) steady state S∗3 (respectively, S
∗
4 ) is deterministically stable,
white areas are regions where the steady state is feasible but unstable, and the black lined area indicates the
region where the steady state is infeasible.
related question to explore concern the role of other cytokines, such as IL-7 [107], TGF-β and IL-10
[73], which are also known to have a significant impact on proliferation of different T cells and
mediating their efficiency in eliminating the infection. Including different cytokines can provide
a better insight into the dynamics of immune response, as has been recently shown in a detailed
model of immune response to hepatitis B [108]. A number of papers have considered time-delayed
stochastic models of cellular processes that also explicitly include cell division, but from a perspec-
tive of direct stochastic simulation [109, 110, 111, 112]. While in the current model, the dynamics
of uninfected cells is described by logistic growth, it would be interesting to explore how one could
include cell division as an alternative and more realistic representation for the dynamics of cell
populations within the framework of SDDEs.
Having computed the variance of stochastic oscillations depending on parameters, it would
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interesting and insightful to compare these results to experimental data on the progress and varia-
tion of autoimmune disease. One possibility for such a comparison is provided by the recent work
on experimental autoimmune uveoretinitis (EAU), where it has been observed that in genetically
identical C57BL/6 mice, once the EAU was induced in them through inoculation, the autoimmune
disease then progressed at slightly different rates [113]. At the same time, in order to be able to
perform such a comparison even at a qualitative level, it is essential to first verify that the main
underlying immunological assumptions of the model hold for the particular experimental systems
being considered, which itself is a challenge from the perspective of being able to measure a signif-
icant number of parameters and cell populations. In this respect, comparing theoretical estimates
of the variance in this model with the measured variability in the numbers of T cells and infected
cells could provide really important insights and validation of the approach developed in this paper.
Appendix A: Table of propensity functions
Propensity functions corresponding to interactions and transitions between cell populations illus-
trated in Fig. 1 and described in deterministic model (1), together with associated state change
vectors, are given by
aj(X) =

sX1, v1 = (1, 0, 0, 0, 0, 0, 0),
X1 (sX1/N + µaX6) , v2 = (−1, 0, 0, 0, 0, 0, 0),
βX1X2, v3 = (−1, 1, 0, 0, 0, 0, 0),
X2 (dF + µFX5 + µaX6) , v4 = (0,−1, 0, 0, 0, 0, 0),
λin, v5 = (0, 0, 1, 0, 0, 0, 0),
dinX3, v6 = (0, 0,−1, 0, 0, 0, 0),
p1αX2X3, v7 = (0, 0,−1, 1, 0, 0, 0),
p2αX2X3, v8 = (0, 0,−1, 0, 1, 0, 0),
(1− p1 − p2)αX2X3, v9 = (0, 0,−1, 0, 0, 1, 0),
λr, v10 = (0, 0, 0, 1, 0, 0, 0),
ρ1X4X7, v11 = (0, 0, 0, 1, 0, 0, 0),
drX4, v12 = (0, 0, 0,−1, 0, 0, 0),
ρ2X5X7, v13 = (0, 0, 0, 0, 1, 0, 0),
dnX5, v14 = (0, 0, 0, 0,−1, 0, 0),
ρ3X6X7, v15 = (0, 0, 0, 0, 0, 1, 0),
X6 (da + δX4) , v16 = (0, 0, 0, 0, 0,−1, 0),
σ1X5 + σ2X6, v17 = (0, 0, 0, 0, 0, 0, 1),
diX7, v18 = (0, 0, 0, 0, 0, 0,−1).
(12)
Appendix B: System-size expansion of propensity functions
Non-delayed reactions:
a2(n) + a3(n) =d2ξ
2






1 + µax1x6 + βx1x2
)
Ω,
a4(n) =µF ξ2ξ5 + µaξ2ξ6 + (dF ξ2 + µFx2ξ5 + µFx5ξ2 + µax2ξ6 + µax6ξ2)Ω
1/2
+ (dFx2 + µFx2x5 + µax2x6)Ω,
a5(n) = λinΩ, a10(n) = λrΩ, a12(n) = drξ4Ω
1/2 + drx4Ω, a14(n) = dnξ5Ω
1/2 + dnx5Ω,
a6(n) + a7(n) + a8(n) + a9(n) = αξ2ξ3 + (dinξ3 + αx2ξ3 + αx3ξ2)Ω
1/2 + (dinx3 + αx2x3)Ω,
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a16(n) = δξ4ξ6 + (daξ6 + δx4ξ6 + δx6ξ4)Ω
1/2 + (dax6 + δx4x6)Ω,
a17(n) = (σ1ξ5 + σ2ξ6)Ω
1/2 + (σ1x5 + σ2x6)Ω, a18(n) = diξ7Ω
1/2 + dix7Ω.
Delayed reactions:
a3(m) = βη1η2 +
(
βx1(t− τ1)η2 + βx2(t− τ1)η1
)
Ω
1/2 + βx1(t− τ1)x2(t− τ1)Ω.
a8(m) = p2αη2η3 +
(
p2αx2(t− τ3)η3 + p2αx3(t− τ3)η2
)
Ω
1/2 + p2αx2(t− τ3)x3(t− τ3)Ω,
a9(m) =(1− p1 − p2)αη2η3 + (1− p1 − p2)
(




+ (1− p1 − p2)αx2(t− τ3)x3(t− τ3)Ω,
a11(m) = ρ1η4η7 +
(
ρ1x4(t− τ2)η7 + ρ1x7(t− τ2)η4
)
Ω
1/2 + ρ1x4(t− τ2)x7(t− τ2)Ω,
a13(m) = ρ2η5η7 +
(
ρ2x5(t− τ2)η7 + ρ2x7(t− τ2)η5
)
Ω
1/2 + ρ2x5(t− τ2)x7(t− τ2)Ω,
a15(m) = ρ3η6η7 +
(
ρ3x6(t− τ2)η7 + ρ3x7(t− τ2)η6
)
Ω
1/2 + ρ3x6(t− τ2)x7(t− τ2)Ω.



















βx1(t− τ1)η2 + βx2(t− τ1)η1
)














ρ1x4(t− τ2)η7 + ρ1x7(t− τ2)η4
)






p1αx2(t− τ3)η3 + p1αx3(t− τ3)η2
)









ρ2x5(t− τ2)η7 + ρ2x7(t− τ2)η5
)






p2αx2(t− τ3)η3 + p2αx3(t− τ3)η2
)











ρ3x6(t− τ2)η7 + ρ3x7(t− τ2)η6
)





(1− p1 − p2)
(
αx2(t− τ3)η3 + αx3(t− τ3)η2
)

















βx1(t− τ1)x2(t− τ1) + dFx2 + µFx2x5 + µax2x6
)∂2Π
∂ξ22















dax6 + δx4x6 + (1− p1 − p2)αx2(t− τ3)x3(t− τ3) + ρ3x6(t− τ2)x7(t− τ2)
)∂2Π
∂ξ26







Table 2: Possible state changes ∆Y during a small time interval ∆t
i (∆Y)Ti Probability Pi∆t
1 (1, 0, 0, 0, 0, 0, 0) sY1(t)∆t
2 (−1, 0, 0, 0, 0, 0, 0)
(
d2Y1(t)
2 + µaY6(t)Y1(t) + βY1(t)Y2(t)
)
∆t
3 (0, 1, 0, 0, 0, 0, 0) βY1(t− τ1)Y2(t− τ1)∆t
4 (0,−1, 0, 0, 0, 0, 0) [dF + µFY5(t) + µaY6(t)]Y2(t)∆t
5 (0, 0, 1, 0, 0, 0, 0) λin∆t
6 (0, 0,−1, 0, 0, 0, 0) [dinY3(t) + αY3(t)Y2(t)] ∆t
7 (0, 0, 0, 1, 0, 0, 0) p1αY3(t− τ3)Y2(t− τ3)∆t
8 (0, 0, 0, 0, 1, 0, 0) p2αY3(t− τ3)Y2(t− τ3)∆t
9 (0, 0, 0, 0, 0, 1, 0) (1− p1 − p2)αY3(t− τ3)Y2(t− τ3)∆t
10 (0, 0, 0, 1, 0, 0, 0) λr∆t
11 (0, 0, 0, 1, 0, 0, 0) ρ1Y7(t− τ2)Y4(t− τ2)∆t
12 (0, 0, 0,−1, 0, 0, 0) drY4(t)∆t
13 (0, 0, 0, 0, 1, 0, 0) ρ2Y7(t− τ2)Y5(t− τ2)∆t
14 (0, 0, 0, 0,−1, 0, 0) dnY5(t)∆t
15 (0, 0, 0, 0, 0, 1, 0) ρ3Y7(t− τ2)Y6(t− τ2)∆t
16 (0, 0, 0, 0, 0,−1, 0) [da + δY4(t)]Y6(t)∆t
17 (0, 0, 0, 0, 0, 0, 1) [σ1Y5(t) + σ2Y6(t)] ∆t
18 (0, 0, 0, 0, 0, 0,−1) diY7(t)∆t





Table 3: Table of parameters
Parameter Value Unit Definition
s 2 day−1 Linear growth rate of uninfected cells
N 20 cell Carrying capacity of uninfected cells
β 0.1 cell−1day−1 Infection rate
µa 4.44 cell
−1day−1 The rate of killing of uninfected cells by autoreactive T cells
da 0.002 day
−1 Natural death rate of autoreactive T cells
dF 2.2 day
−1 Natural death rate of infected cells
δ 4.4e-4 cell−1day−1 Rate of clearance of autoreactive T cells by regulatory T cells
µF 1.33 cell
−1day−1 The rate of killing of infected cells by the normal T cells
σ1 0.3 day
−1 Rate of production of IL-2 by normal T cells
σ2 0.4 day
−1 Rate of production of IL-2 by autoreactive T cells
λin 18 cell day
−1 Growth rate of inactive T cells
din 2 day
−1 Natural death rate of inactive T cells
di 1.2 day
−1 Natural clearance rate of IL-2
α 0.04 cell−1day−1 Rate of activation of inactive T cells by infected cells
λr 54 cell day
−1 Growth rate of regulatory T cells
dr 0.8 day
−1 Natural death rate of regulatory T cells
p1 0.4 – Proportion of T cells differentiating into regulatory T cells
p2 0.4 – Proportion of T cells differentiating into normal T cells
ρ1 2.22 cell
−1day−1 Proliferation rate of regulatory T cells by IL-2
ρ2 0.178 cell
−1day−1 Proliferation rate of normal T cells by IL-2
ρ3 0.44 cell
−1day−1 Proliferation rate of autoreactive T cells by IL-2
dn 2 day
−1 Natural death rate of normal T cells
τ1 0.7 day Viral lag
τ2 0.5 day Delay in IL-2 enhanced proliferation of T cells
τ3 0.3 day Delay in T cell differentiation/expansion
Ω 1000 cell System size
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homeostasis of näıve and memory CD8 T cells in vivo,” Nature Immunol., vol. 1, pp. 426–432,
2000.
[108] F. Fatehi Chenar, Y. N. Kyrychko, and K. B. Blyuss, “Mathematical model of immune
response to hepatitis B,” J. Theor. Biol., vol. 447, pp. 98–110, 2018.
[109] L. Chen, R. Wnag, T. Zhou, and K. Aihara, “Noise-induced cooperative behavior in a mul-
ticell system,” Bioinf., vol. 21, pp. 2722–2729, 2005.
[110] R. Luo, L. Ye, C. Tao, and K. Wang, “Simulation of E. coli gene regulation including overlap-
ping cell cycles, growth, division, time delays and noise,” PLoS ONE, vol. 8, no. 4, p. e62380,
2013.
[111] S. Nakaoka and K. Aihara, “Stochastic simulation of structured skin cell population dynam-
ics,” J. Math. Biol, vol. 66, pp. 807–835, 2013.
[112] T. R. Maarleveld, B. G. Olivier, and F. J. Bruggeman, “Stochpy: a comprehensive, user-
friendly tool for simulating stochastic biological processes,” PLoS ONE, vol. 8, no. 11,
p. e79345, 2013.
[113] J. Boldison, T. K. Khera, D. A. Copland, M. L. Stimpson, G. L. Crawford, A. D. Dick, et al.,
“A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental
autoimmune uveoretinitis,” Immunology, vol. 146, pp. 301–311, 2015.
27
